August 27, 2020 – Morgan Hill, CA – Mitre Medical Corp. (“Mitre Medical” or “company”), an early-stage medical device company developing the Mitral Touch®, a less invasive and safer approach to treat mitral valve regurgitation (MR) and remodel the left ventricle (LV) in patients with moderate to severe MR, has retained Zimmons International Communications, Inc. (“Zimmons International”), based in New York City, as the company’s financial communications counselor and investor relations firm.
Zimmons International will assist Mitre Medical in developing and managing investor relations initiatives and activities aimed at raising Mitre Medical’s corporate profile among investors. Specific emphasis will be on increasing the awareness of Mitre Medical among family offices, specialized healthcare funds, and strategic entities.
“As Mitre Medical works with the FDA and progresses with clinical trials to introduce Mitral Touch® to US doctors and patients, we believe now is the time to start communicating our opportunity. Retaining an investor relations and communications expert is a strategic step. Currently, Zimmons International is working with Mitre Medical to identify family offices, specialized healthcare funds, and investors with an interest in emerging healthcare technologies. As Mitre Medical advances its business, we feel that informing the financial community of our achievements will provide investors with the most timely and up-to-date information to make an investment decision,” stated John MacMahon, Chief Executive Officer of Mitre Medial.
“I am delighted to be working with Mitre Medical, especially during this pivotal inflection point in the company’s history. Cardiovascular health is a major issue for patients and doctors in the global healthcare system. Supporting Mitre Medical with its investor awareness efforts will in turn help Mitre Medical achieve its goal of offering an innovative solution that can help millions of patients,” stated Jennifer K. Zimmons, Ph.D., President of Zimmons International.
About Mitre Medical Corp.
Mitre Medical Corp is an early-stage medical device company developing the Mitral Touch®, a less invasive and safer approach to treat mitral valve regurgitation (MR) and remodel the left ventricle (LV) in patients with moderate to severe MR. Mitre Medical has the potential to be the new standard of care for MR. For more information, please visit www.mitremedical.com.
About Zimmons International Communications, Inc.
Zimmons International Communications, Inc. (“ZIC”) is a boutique investor relations firm based in New York founded by Jennifer K. Zimmons, Ph.D. ZIC specializes in working with international companies as well as with portfolio companies of family offices and private equity firms. Clients include both public and private entities. ZIC’s client base is composed of emerging healthcare opportunities as well as technology, resources, and consumer health companies. Dr. Zimmons also serves as the Program Committee Chair for Women in BIO (New York Chapter) as well as board member for a family office focusing on emerging and frontier markets. For more information, please visit www.zimmonsic.com.
Forward Looking Statements
This press release includes forward-looking statements including, but not limited to, statements related to the development of our technology, our operations and business strategy, our expected financial results, and corporate updates. The forward-looking statements contained in this press release are based on management’s current expectations and are subject to substantial risks, uncertainty and changes in circumstances. Actual results may differ materially from those expressed by these expectations due to risks and uncertainties. Forward-looking statements speak only as of the date of this press release, and we undertake no obligation to review or update any forward-looking statement except as may be required by applicable law.
Mitre Medical Corp.:
Chief Executive Officer
18655 Madrone Parkway
Morgan Hill, CA 95037
Jennifer K. Zimmons, Ph.D.
Zimmons International Communications
Tel: +1 917.214.3514
Source: Mitre Medical Corp.